Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
1127
-
Total shares
-
72.6M
-
Shares change
-
-275K
-
Total reported value, excl. options
-
$40.3B
-
Value change
-
+$36.8M
-
Put/Call ratio
-
0.93
-
Number of buys
-
462
-
Number of sells
-
-499
-
Price
-
$555.05
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q4 2023
1,147 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q4 2023.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.6M shares
of 80.8M outstanding shares and own 89.81% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.05M shares), VANGUARD GROUP INC (8.38M shares), STATE STREET CORP (3.78M shares), ALLIANCEBERNSTEIN L.P. (2.94M shares), Fundsmith LLP (2.73M shares), BAMCO INC /NY/ (2.3M shares), GEODE CAPITAL MANAGEMENT, LLC (2.1M shares), FRANKLIN RESOURCES INC (1.41M shares), Invesco Ltd. (1.33M shares), and BLAIR WILLIAM & CO/IL (1.2M shares).
This table shows the top 1127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.